-
Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer - 10/3/2023
1:01:01
-
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma - 9/26/2023
1:01:33
-
Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer - 9/21/2023
1:01:39
-
Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer - 9/20/2023
1:05:23
-
Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer - 9/11/2023
1:04:48
-
Cases from the Community: Investigators Discuss the Application of Available Research in the Care of Patients with Diffuse Large B-Cell Lymphoma - 9/8/2023
58:29
-
Consensus or Controversy? Documenting and Discussing Clinical Investigators’ Practice Patterns in Myelofibrosis - 9/7/2023
56:47
-
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors - 8/30/2023
1:02:58
-
Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer - 8/8/2023
1:03:48
-
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma - 8/2/2023
1:00:41
-
Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer - 7/31/2023
1:01:00
- Next Page